{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:28:42Z","timestamp":1793860122245,"version":"4.6.1"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11618-y","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:46:40Z","timestamp":1781531200000},"page":"9167-9201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent trends in anti-Alzheimer\u2019s potential of novel biologically active isatin analogues: synthetic strategies, structural activity relationship studies and molecular docking insights"],"prefix":"10.1007","volume":"30","author":[{"given":"Rajarshi","family":"Nath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhic","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Jawaid","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrajit","family":"Maity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swastika","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupender","family":"Nehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumel","family":"Ashique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah Alam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyadeep","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplab","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Yasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibullah","family":"Khalilullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Yousuf","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"16","key":"11618_CR1","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1080\/17568919.2024.2366159","volume":"16","author":"S Khan","year":"2024","unstructured":"Khan S, Hussain R, Iqbal T, Khan Y, Jamal U, Darwish HW et al (2024) Identification of novel benzothiazole\u2013thiadiazole-based thiazolidinone derivative: in vitro and in silico approaches to develop promising anti-Alzheimer\u2019s agents. Future Med Chem 16(16):1601\u20131613","journal-title":"Future Med Chem"},{"issue":"11","key":"11618_CR2","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00044-022-02953-4","volume":"31","author":"H Kumar","year":"2022","unstructured":"Kumar H, Goyal A, Kumar N, Garg P, Design (2022) Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer\u2019s disease. Med Chem Res 31(11):1931\u20131947","journal-title":"Med Chem Res"},{"key":"11618_CR3","doi-asserted-by":"crossref","unstructured":"Majee C, Mazumder R, Pantela B (2025) Neurodegenerative disorders: concepts, types, and treatment strategies. In: Nanomedicine for neurodegenerative disorders. Apple Academic. pp 1\u201336","DOI":"10.1201\/9781003486565-1"},{"key":"11618_CR4","doi-asserted-by":"publisher","first-page":"100872","DOI":"10.1016\/j.cophys.2025.100872","volume":"30","author":"S Tanveer","year":"2025","unstructured":"Tanveer S, Bajpai A, Rajput SJ, Saravanan P, Patel BK (2025) Targeting oxidative stress to combat neurodegenerative diseases, ALS and Huntington\u2019s, for better brain health and recovery. Curr Opin Physiol 30:100872","journal-title":"Curr Opin Physiol"},{"issue":"1","key":"11618_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-025-08186-8","volume":"17","author":"AA Abdulkhaliq","year":"2026","unstructured":"Abdulkhaliq AA, Kim B, Almoghrabi YM, Khan J, Ajoolabady A, Ren J, Bahijri S, Tuomilehto J, Borai A, Pratico D (2026) Amyloid-\u03b2 and Tau in Alzheimer\u2019s disease: pathogenesis, mechanisms, and interplay. Cell Death Dis 17(1):21","journal-title":"Cell Death Dis"},{"issue":"4","key":"11618_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/biom16040595","volume":"16","author":"L Stru\u017cy\u0144ska","year":"2026","unstructured":"Stru\u017cy\u0144ska L, Adamiak K, Sidoryk-W\u0119grzynowicz M (2026) Tau and \u03b2-amyloid relevant pathology as a central therapeutic target in Alzheimer\u2019s disease. Biomolecules 16(4):595","journal-title":"Biomolecules"},{"issue":"19","key":"11618_CR7","doi-asserted-by":"publisher","first-page":"14794","DOI":"10.3390\/ijms241914794","volume":"24","author":"KS Orobets","year":"2023","unstructured":"Orobets KS, Karamyshev AL (2023) Amyloid precursor protein and Alzheimer\u2019s disease. Int J Mol Sci 24(19):14794","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11618_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12013-024-01248-2","volume":"82","author":"BE Ekundayo","year":"2024","unstructured":"Ekundayo BE, Obafemi TO, Adewale OB, Obafemi BA, Oyinloye BE, Ekundayo SK (2024) Oxidative stress, endoplasmic reticulum stress and apoptosis in the pathology of Alzheimer\u2019s disease. Cell Biochem Biophys 82(2):457\u2013477","journal-title":"Cell Biochem Biophys"},{"issue":"19","key":"11618_CR9","doi-asserted-by":"publisher","first-page":"10797","DOI":"10.3390\/ijms251910797","volume":"25","author":"S Kotarba","year":"2024","unstructured":"Kotarba S, Koz\u0142owska M, Scios M, Saramowicz K, Barczuk J, Granek Z, Siwecka N, Wiese W, Golberg M, Galita G, Sychowski G (2024) Potential mechanisms of tunneling nanotube formation and their role in pathology spread in Alzheimer\u2019s disease and other proteinopathies. Int J Mol Sci 25(19):10797","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11618_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s40001-025-02886-9","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang J, Kong G, Yang J, Pang L, Li X (2025) Pathological mechanisms and treatment progression of Alzheimer\u2019s disease. Eur J Med Res 30(1):625","journal-title":"Eur J Med Res"},{"issue":"8","key":"11618_CR11","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3390\/ijms26083905","volume":"26","author":"H Xing","year":"2025","unstructured":"Xing H, Yue S, Qin R, Du X, Wu Y, Zhangsun D et al (2025) Recent advances in drug development for Alzheimer\u2019s disease: a comprehensive review. Int J Mol Sci 26(8):3905","journal-title":"Int J Mol Sci"},{"issue":"6","key":"11618_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/diseases12060110","volume":"12","author":"CA Valdez-Gaxiola","year":"2024","unstructured":"Valdez-Gaxiola CA, Rosales-Leycegui F, Gaxiola-Rubio A, Moreno-Ortiz JM, Figuera LE (2024) Early-and late-onset alzheimer\u2019s disease: two sides of the same coin? Diseases 12(6):110","journal-title":"Diseases"},{"issue":"2","key":"11618_CR13","first-page":"389","volume":"36","author":"S Markos","year":"2025","unstructured":"Markos S, Galibov M (2025) Rehabilitation of women with neurodegenerative diseases. Phys Med Rehabilitation Clin 36(2):389\u2013398","journal-title":"Phys Med Rehabilitation Clin"},{"key":"11618_CR14","doi-asserted-by":"crossref","unstructured":"Kamble SM, Patil KR, Upaganlawar AB (2024) Etiology, pathogenesis of Alzheimer\u2019s disease and amyloid beta hypothesis. In: Alzheimer\u2019s disease and advanced drug delivery strategies. Academic Press. pp 1\u201311","DOI":"10.1016\/B978-0-443-13205-6.00022-4"},{"key":"11618_CR15","doi-asserted-by":"publisher","first-page":"1303111","DOI":"10.3389\/fneur.2023.1303111","volume":"14","author":"S Suresh","year":"2023","unstructured":"Suresh S, Singh SA, Rushendran R, Vellapandian C, Prajapati B (2023) Alzheimer\u2019s disease: the role of extrinsic factors in its development, an investigation of the environmental enigma. Front Neurol 14:1303111","journal-title":"Front Neurol"},{"issue":"8","key":"11618_CR16","doi-asserted-by":"publisher","first-page":"6793","DOI":"10.1021\/acs.jmedchem.4c00355","volume":"67","author":"L Wang","year":"2024","unstructured":"Wang L, Sun T, Zhen T, Li W, Yang H, Wang S, Feng F, Chen Y, Sun H (2024) Butyrylcholinesterase-activated near-infrared fluorogenic probe for in vivo theranostics of Alzheimer\u2019s disease. J Med Chem 67(8):6793\u20136809","journal-title":"J Med Chem"},{"issue":"17","key":"11618_CR17","doi-asserted-by":"publisher","first-page":"8726","DOI":"10.3390\/ijms26178726","volume":"26","author":"W Grabowska","year":"2025","unstructured":"Grabowska W, Bijak M, Szelenberger R, Gorniak L, Podogrocki M, Harmata P, Cichon N (2025) Acetylcholinesterase as a multifunctional target in amyloid-driven neurodegeneration: From dual-site inhibitors to anti-agregation strategies. Int J Mol Sci 26(17):8726","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11618_CR18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.drudis.2020.12.004","volume":"26","author":"S Bhatt","year":"2021","unstructured":"Bhatt S, Puli L, Patil CR (2021) Role of reactive oxygen species in the progression of Alzheimer\u2019s disease. Drug Discov Today 26(3):794\u2013803","journal-title":"Drug Discov Today"},{"issue":"12","key":"11618_CR19","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/molecules26123724","volume":"26","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G et al (2021) Role of monoamine oxidase activity in Alzheimer\u2019s disease: an insight into the therapeutic potential of inhibitors. Molecules 26(12):3724","journal-title":"Molecules"},{"issue":"3","key":"11618_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/futurepharmacol5030051","volume":"5","author":"LE Cobos-Puc","year":"2025","unstructured":"Cobos-Puc LE, Rodr\u00edguez-Salazar MD, Silva-Belmares SY, Aguayo-Morales H (2025) Nanoparticle-based strategies to enhance catecholaminergic drug delivery for neuropsychiatric disorders: advances, challenges, and therapeutic opportunities. Future Pharmacol 5(3):51","journal-title":"Future Pharmacol"},{"issue":"7","key":"11618_CR21","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.3390\/ijms24076459","volume":"24","author":"R Schulz","year":"2023","unstructured":"Schulz R, Schl\u00fcter KD (2023) Importance of mitochondria in cardiac pathologies: focus on uncoupling proteins and monoamine oxidases. Int J Mol Sci 24(7):6459","journal-title":"Int J Mol Sci"},{"key":"11618_CR22","doi-asserted-by":"publisher","first-page":"115308","DOI":"10.1016\/j.ejmech.2023.115308","volume":"252","author":"C Yi","year":"2023","unstructured":"Yi C, Liu X, Chen K, Liang H, Jin C (2023) Design, synthesis and evaluation of novel monoamine oxidase B (MAO-B) inhibitors with improved pharmacokinetic properties for Parkinson\u2019s disease. Eur J Med Chem 252:115308","journal-title":"Eur J Med Chem"},{"key":"11618_CR23","doi-asserted-by":"publisher","first-page":"101957","DOI":"10.1016\/j.jchemneu.2021.101957","volume":"114","author":"DN Jones","year":"2021","unstructured":"Jones DN, Raghanti MA (2021) The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders. J Chem Neuroanat 114:101957","journal-title":"J Chem Neuroanat"},{"issue":"38","key":"11618_CR24","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.2174\/1381612827666210612051713","volume":"27","author":"MS Rahman","year":"2021","unstructured":"Rahman MS, Uddin MS, Rahman MA, Samsuzzaman M, Behl T, Hafeez A, Perveen A, Barreto GE, Ashraf GM (2021) Exploring the role of monoamine oxidase activity in aging and Alzheimer\u2019s disease. Curr Pharm Design 27(38):4017\u20134029","journal-title":"Curr Pharm Design"},{"key":"11618_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11062-026-09995-z","volume":"56","author":"S Gupta","year":"2024","unstructured":"Gupta S, Aran K (2024) Unlocking the P2X7 pathway: a therapeutic target in Alzheimer\u2019s disease. Neurophysiology 56:203\u2013217","journal-title":"Neurophysiology"},{"issue":"10","key":"11618_CR26","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jamaneurol.2022.2793","volume":"79","author":"S Shcherbinin","year":"2022","unstructured":"Shcherbinin S, Evans CD, Lu M, Andersen SW, Pontecorvo MJ, Willis BA et al (2022) Association of amyloid reduction after donanemab treatment with tau pathology and clinical outcomes: the TRAILBLAZER-ALZ randomized clinical trial. JAMA Neurol 79(10):1015\u20131024","journal-title":"JAMA Neurol"},{"issue":"6","key":"11618_CR27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","volume":"29","author":"CJ Mummery","year":"2023","unstructured":"Mummery CJ, B\u00f6rjesson-Hanson A, Blackburn DJ, Vijverberg EGB, De Deyn PP, Ducharme S et al (2023) Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial. Nat Med 29(6):1437\u20131447","journal-title":"Nat Med"},{"issue":"6","key":"11618_CR28","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong FF (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules 27(6):1816","journal-title":"Molecules"},{"key":"11618_CR29","doi-asserted-by":"publisher","first-page":"1476909","DOI":"10.3389\/fnagi.2024.1476909","volume":"16","author":"FJ Barrantes","year":"2024","unstructured":"Barrantes FJ (2024) Cognitive synaptopathy: synaptic and dendritic spine dysfunction in age-related cognitive disorders. Front Aging Neurosci 16:1476909","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"11618_CR30","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s12035-024-04333-y","volume":"62","author":"E Akyuz","year":"2025","unstructured":"Akyuz E, Arulsamy A, Aslan FS, Saris\u00f6zen B, Guney B, Hekimoglu A, Yilmaz BN, Retinasamy T, Shaikh MF (2025) An expanded narrative review of neurotransmitters on Alzheimer\u2019s disease: the role of therapeutic interventions on neurotransmission. Mol Neurobiol 62(2):1631\u20131674","journal-title":"Mol Neurobiol"},{"key":"11618_CR31","first-page":"1","volume":"6","author":"P Sharma","year":"2026","unstructured":"Sharma P, Subhan A, Saklania S, Thareja S (2026) Phytometabolites as therapeutics for Alzheimer\u2019s disease: mechanistic insights into neuroprotection and amyloid clearance. Phytochem Rev 6:1\u201340","journal-title":"Phytochem Rev"},{"issue":"1","key":"11618_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10787-025-02041-0","volume":"34","author":"A Shafi","year":"2026","unstructured":"Shafi A, Akmal M, Sethi A, Chauhdary Z (2026) A mechanistic insight of neuro-inflammation signaling pathways and implication in neurodegenerative disorders. Inflammopharmacology 34(1):309\u2013318","journal-title":"Inflammopharmacology"},{"issue":"2","key":"11618_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neurad.2023.09.003","volume":"51","author":"L Velu","year":"2024","unstructured":"Velu L, Pellerin L, Julian A, Paccalin M, Giraud C, Fayolle P, Guillevin R, Guillevin C (2024) Early rise of glutamate-glutamine levels in mild cognitive impairment: Evidence for emerging excitotoxicity. J Neuroradiol 51(2):168\u2013175","journal-title":"J Neuroradiol"},{"issue":"2","key":"11618_CR34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1570159X20666211223140303","volume":"21","author":"IB de Lima","year":"2023","unstructured":"de Lima IB, Ribeiro FM (2023) The implication of glial metabotropic glutamate receptors in Alzheimer\u2019s disease. Curr Neuropharmacol 21(2):164\u2013182","journal-title":"Curr Neuropharmacol"},{"key":"11618_CR35","doi-asserted-by":"publisher","first-page":"956204","DOI":"10.3389\/fphar.2022.956204","volume":"13","author":"P-N Wu","year":"2022","unstructured":"Wu P-N, Xiong S, Zhong P, Yang W-Q, Chen M, Tang T-C (2022) Global trends in research on irritable bowel syndrome and the brain\u2013gut axis: Bibliometrics and visualization analysis. Front Pharmacol 13:956204","journal-title":"Front Pharmacol"},{"key":"11618_CR36","doi-asserted-by":"publisher","first-page":"821654","DOI":"10.3389\/fnins.2021.821654","volume":"15","author":"F Wang","year":"2022","unstructured":"Wang F, Fei M, Hu W-Z, Wang X-D, Liu S, Zeng Y et al (2022) Prevalence of constipation in elderly and its association with dementia and mild cognitive impairment: a cross-sectional study. Front NeuroSci 15:821654","journal-title":"Front NeuroSci"},{"issue":"6","key":"11618_CR37","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/nu16060852","volume":"16","author":"M Kossowska","year":"2024","unstructured":"Kossowska M, Olejniczak S, Karbowiak M, Mosiej W, Zieli\u0144ska D, Brzezicka A (2024) The interplay between gut microbiota and cognitive functioning in the healthy aging population: a systematic review. Nutrients 16(6):852","journal-title":"Nutrients"},{"issue":"3","key":"11618_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.31083\/j.fbl2903118","volume":"29","author":"VN Nikolenko","year":"2024","unstructured":"Nikolenko VN, Borminskaya ID, Nikitina AT, Golyshkina MS, Rizaeva NA, Oganesyan MV (2024) Locus coeruleus-norepinephrine system: spheres of influence and contribution to the development of neurodegenerative diseases. Front Bioscience-Landmark 29(3):118","journal-title":"Front Bioscience-Landmark"},{"issue":"3","key":"11618_CR39","doi-asserted-by":"publisher","first-page":"e14420","DOI":"10.1111\/acel.14420","volume":"24","author":"JH Jeong","year":"2025","unstructured":"Jeong JH, Kim DK, Chung S, Han JW, Han J, Mook-Jung I (2025) Long\u2010term exposure to excessive norepinephrine in the brain induces tau aggregation, neuronal death, and cognitive deficits in early tau transgenic mice. Aging Cell 24(3):e14420","journal-title":"Aging Cell"},{"issue":"12","key":"11618_CR40","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3390\/biology11121822","volume":"11","author":"D Mercan","year":"2022","unstructured":"Mercan D, Heneka MT (2022) The contribution of the locus coeruleus\u2013noradrenaline system degeneration during the progression of alzheimer\u2019s disease. Biology 11(12):1822","journal-title":"Biology"},{"issue":"4","key":"11618_CR41","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1007\/s12035-024-04543-4","volume":"62","author":"ZL Almeida","year":"2025","unstructured":"Almeida ZL, Vaz DC, Brito RM (2025) Morphological and molecular profiling of amyloid-\u03b2 species in Alzheimer\u2019s pathogenesis. Mol Neurobiol 62(4):4391\u20134419","journal-title":"Mol Neurobiol"},{"issue":"2","key":"11618_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/ijms25020831","volume":"25","author":"H Shi","year":"2024","unstructured":"Shi H, Zhao Y (2024) Modulation of tau pathology in Alzheimer\u2019s disease by dietary bioactive compounds. Int J Mol Sci 25(2):831","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11618_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflamm 20(1):165","journal-title":"J Neuroinflamm"},{"issue":"8","key":"11618_CR44","doi-asserted-by":"publisher","first-page":"e31274","DOI":"10.1002\/jcp.31274","volume":"239","author":"JD Villeda-Gonz\u00e1lez","year":"2024","unstructured":"Villeda-Gonz\u00e1lez JD, G\u00f3mez\u2010Olivares JL, Baiza\u2010Gutman LA (2024) New paradigms in the study of the cholinergic system and metabolic diseases: Acetyl\u2010and\u2010butyrylcholinesterase. J Cell Physiol 239(8):e31274","journal-title":"J Cell Physiol"},{"issue":"2","key":"11618_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/13543776.2025.2602702","volume":"36","author":"P Begines","year":"2026","unstructured":"Begines P, Fern\u00e1ndez-Bola\u00f1os JG, L\u00f3pez \u00d3 (2026) An updated patent review of acetylcholinesterase inhibitors for the treatment of alzheimer\u2019s disease (2021\u2013present). Expert Opin Ther Pat 36(2):159\u2013190","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"11618_CR46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s11033-025-10349-x","volume":"52","author":"MO Oyovwi","year":"2025","unstructured":"Oyovwi MO, Udi OA, Atere AD, Joseph GU, Ogbutor UG (2025) Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy. Mol Biol Rep 52(1):240","journal-title":"Mol Biol Rep"},{"key":"11618_CR47","doi-asserted-by":"publisher","first-page":"1582119","DOI":"10.3389\/fimmu.2025.1582119","volume":"16","author":"W Lei","year":"2025","unstructured":"Lei W, Cheng Y, Liu X, Gao J, Zhu Z, Ding W, Xu X, Li Y, Ling Z, Jiang R, Chen X (2025) Gut microbiota-driven neuroinflammation in Alzheimer\u2019s disease: from mechanisms to therapeutic opportunities. Front Immunol 16:1582119","journal-title":"Front Immunol"},{"issue":"7","key":"11618_CR48","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3390\/molecules29071478","volume":"29","author":"H Chen","year":"2024","unstructured":"Chen H, Zeng Y, Wang D, Li Y, Xing J, Zeng Y, Liu Z, Zhou X, Fan H (2024) Neuroinflammation of microglial regulation in Alzheimer\u2019s disease: therapeutic approaches. Molecules 29(7):1478","journal-title":"Molecules"},{"issue":"7","key":"11618_CR49","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2174\/1871527322666221223091529","volume":"23","author":"MU Ali","year":"2024","unstructured":"Ali MU, Anwar L, Ali MH, Iqubal MK, Iqubal A, Baboota S, Ali J (2024) Signalling pathways involved in microglial activation in Alzheimer\u2019s disease and potential neuroprotective role of phytoconstituents. CNS Neurol Disord-Drug Targets-CNS Neurol Disord 23(7):819\u2013840","journal-title":"CNS Neurol Disord-Drug Targets-CNS Neurol Disord"},{"issue":"2","key":"11618_CR50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1570159X19666210916102638","volume":"21","author":"KS Abd-Elrahman","year":"2023","unstructured":"Abd-Elrahman KS, Sarasija S, Ferguson SS (2023) The role of neuroglial metabotropic glutamate receptors in Alzheimer\u2019s disease. Curr Neuropharmacol 21(2):273\u2013283","journal-title":"Curr Neuropharmacol"},{"key":"11618_CR51","doi-asserted-by":"publisher","first-page":"112601","DOI":"10.1016\/j.jinorgbio.2024.112601","volume":"257","author":"T Mazur","year":"2024","unstructured":"Mazur T, Malik M, Bie\u0144ko DC (2024) The impact of chelating compounds on Cu2+, Fe2+\/3+, and Zn2\u2009+\u2009ions in Alzheimer\u2019s disease treatment. J Inorg Biochem 257:112601","journal-title":"J Inorg Biochem"},{"issue":"10","key":"11618_CR52","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/jat.4833","volume":"45","author":"YQ Mo","year":"2025","unstructured":"Mo YQ, Zhong JY, Teng MJ, Peng JC, Huang H, Aschner M, Jiang YM (2025) Advances in research on neurotoxicity and mechanisms of manganese, iron, and copper exposure, alone or in combination. J Appl Toxicol 45(10):1968\u20131983","journal-title":"J Appl Toxicol"},{"issue":"10","key":"11618_CR53","doi-asserted-by":"publisher","first-page":"e70091","DOI":"10.1111\/cns.70091","volume":"30","author":"J Yang","year":"2024","unstructured":"Yang J, Liang J, Hu N, He N, Liu B, Liu G, Qin Y (2024) The gut microbiota modulates neuroinflammation in Alzheimer\u2019s disease: elucidating crucial factors and mechanistic underpinnings. CNS Neurosci Ther 30(10):e70091","journal-title":"CNS Neurosci Ther"},{"key":"11618_CR54","doi-asserted-by":"publisher","first-page":"135945","DOI":"10.1016\/j.molstruc.2023.135945","volume":"1291","author":"Y Khan","year":"2023","unstructured":"Khan Y, Rehman W, Hussain R, Khan S, Maalik A (2023) Benzothiazole-based 1, 3, 4-thiadiazole hybrids derivatives as effective inhibitors of urease and thymidine phosphorylase: synthesis, in vitro and in silico approaches. J Mol Struct 1291:135945","journal-title":"J Mol Struct"},{"issue":"7","key":"11618_CR55","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2174\/1389557523666221201145141","volume":"23","author":"C Yamali","year":"2023","unstructured":"Yamali C, Donmez S (2023) Recent developments in tacrine-based hybrids as a therapeutic option for Alzheimer\u2019s disease. Mini Rev Med Chem 23(7):869\u2013880","journal-title":"Mini Rev Med Chem"},{"issue":"36","key":"11618_CR56","doi-asserted-by":"publisher","first-page":"23626","DOI":"10.1039\/D2RA03803J","volume":"12","author":"\u015e Karaca","year":"2022","unstructured":"Karaca \u015e, Osmaniye D, Sa\u011fl\u0131k BN, Levent S, Ilg\u0131n S, \u00d6zkay Y et al (2022) Synthesis of novel benzothiazole derivatives and investigation of their enzyme inhibitory effects against Alzheimer\u2019s disease. RSC Adv 12(36):23626\u201323636","journal-title":"RSC Adv"},{"key":"11618_CR57","doi-asserted-by":"crossref","unstructured":"Truong B, Quiroz JP, Priefer R (2020) Acetylcholinesterase inhibitors for Alzheimer\u2019s disease: past, present, and potential future. Med Res Arch 8(12)","DOI":"10.18103\/mra.v8i12.2271"},{"issue":"12","key":"11618_CR58","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1080\/17425247.2024.2414768","volume":"21","author":"S Chakraborty","year":"2024","unstructured":"Chakraborty S, Vishwas S, Harish V, Gupta G, Paudel KR, Dhanasekaran M, Goh BH, Zacconi F, de Jesus Andreoli Pinto T, Kumbhar P, Disouza J (2024) Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer\u2019s disease: current approaches and future perspectives. Expert Opin Drug Deliv 21(12):1771\u20131792","journal-title":"Expert Opin Drug Deliv"},{"key":"11618_CR59","doi-asserted-by":"publisher","first-page":"154600","DOI":"10.1016\/j.phymed.2022.154600","volume":"109","author":"M Yang","year":"2023","unstructured":"Yang M, Zhang X, Qiao O, Ji H, Zhang Y, Han X, Wang W, Li X, Wang J, Guo L, Huang L (2023) Rosmarinic acid potentiates and detoxifies tacrine in combination for Alzheimer\u2019s disease. Phytomedicine 109:154600","journal-title":"Phytomedicine"},{"issue":"7","key":"11618_CR60","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/phar.70031","volume":"45","author":"BW Gilbert","year":"2025","unstructured":"Gilbert BW, Santiago RD, Huffman JB, Yoder NM, Hunninghake JC (2025) Transdermal rivastigmine as a therapeutic option in severe diphenhydramine-induced anticholinergic toxicity: a case report and literature review. Pharmacother: J Hum Pharmacol Drug Ther 45(7):462\u2013467","journal-title":"Pharmacother: J Hum Pharmacol Drug Ther"},{"issue":"2","key":"11618_CR61","doi-asserted-by":"publisher","first-page":"e001079","DOI":"10.1136\/bmjno-2025-001079","volume":"7","author":"I Cani","year":"2025","unstructured":"Cani I, Grotteschi N, Calandra-Buonaura G, Guarino M, Guaraldi P, Giannini G, Baldelli L, Donati M, Cortelli P, Camerlingo MD, Nonino F (2025) Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson\u2019s disease without dementia: a systematic review. BMJ Neurol Open 7(2):e001079","journal-title":"BMJ Neurol Open"},{"key":"11618_CR62","doi-asserted-by":"publisher","first-page":"1655893","DOI":"10.3389\/fimmu.2025.1655893","volume":"16","author":"AA Desai","year":"2025","unstructured":"Desai AA, Smith MD, Zupancic JM, Makowski EK, Zhang Y, Gerson JE, Moore SJ, Sutter AB, Ferris SP, Ivanova MI, Murphy GG (2025) Directed evolution of drug-like A\u03b2 conformation-specific antibodies. Front Immunol 16:1655893","journal-title":"Front Immunol"},{"key":"11618_CR63","doi-asserted-by":"publisher","first-page":"108471","DOI":"10.1016\/j.jmgm.2023.108471","volume":"122","author":"E Mateev","year":"2023","unstructured":"Mateev E, Kondeva-Burdina M, Georgieva M, Zlatkov A (2023) Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer\u2019s disease: An in silico and in vitro study. J Mol Graph Model 122:108471","journal-title":"J Mol Graph Model"},{"issue":"1","key":"11618_CR64","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00401-024-02712-2","volume":"147","author":"M Jaisa-Aad","year":"2024","unstructured":"Jaisa-Aad M, Mu\u00f1oz-Castro C, Healey MA, Hyman BT, Serrano-Pozo A (2024) Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer\u2019s disease and related dementias. Acta Neuropathol 147(1):66","journal-title":"Acta Neuropathol"},{"issue":"1","key":"11618_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41983-025-00968-3","volume":"61","author":"TB Ameen","year":"2025","unstructured":"Ameen TB, Ali U, Salma O, Abdul Samee M, Iraj Abbas SM, Naveera Kashif S, Arif Arifi M, Ali M, Khowaja M, Sinaan Ali SM, Raheem A (2025) Amyloid solutions: lecanemab, gantenerumab, and donanemab in the treatment of Alzheimer\u2019s disease. Egypt J Neurol Psychiatry Neurosurg 61(1):37","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"11618_CR66","doi-asserted-by":"publisher","first-page":"1599048","DOI":"10.3389\/fphar.2025.1599048","volume":"16","author":"H Wang","year":"2025","unstructured":"Wang H, Pan J, Zhang M, Tan Z (2025) Re-evaluation of the efficacy and safety of anti-A\u03b2 monoclonal antibodies (lecanemab\/donanemab) in the treatment of early Alzheimer\u2019s disease. Front Pharmacol 16:1599048","journal-title":"Front Pharmacol"},{"issue":"11","key":"11618_CR67","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/ph18111685","volume":"18","author":"M Almaghrabi","year":"2025","unstructured":"Almaghrabi M (2025) Multitarget-directed ligands for Alzheimer\u2019s disease: recent novel MTDLs and mechanistic insights. Pharmaceuticals 18(11):1685","journal-title":"Pharmaceuticals"},{"key":"11618_CR68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.64943\/ljmas.v2i1.25","volume":"15","author":"EM Khalefa","year":"2024","unstructured":"Khalefa EM, Altumi SA, Eldawi NS (2024) Targeting Alzheimer\u2019s disease: current pharmacological strategies and emerging therapies. Libyan J Med Appl Sci 15:45\u201350","journal-title":"Libyan J Med Appl Sci"},{"issue":"1","key":"11618_CR69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s40473-026-00327-3","volume":"13","author":"S Tyagi","year":"2026","unstructured":"Tyagi S, Tyagi A, Shekhar N (2026) Donepezil-a double-edged sword in Alzheimer\u2019s disease? Curr Behav Neurosci Rep 13(1):8","journal-title":"Curr Behav Neurosci Rep"},{"issue":"5","key":"11618_CR70","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1021\/acschemneuro.3c00656","volume":"15","author":"C Mugnaini","year":"2024","unstructured":"Mugnaini C, Brizzi A, Paolino M, Scarselli E, Castelli R, De Candia M, Gambacorta N, Nicolotti O, Kostrzewa M, Kumar P, Mahmoud AM (2024) Novel dual-acting hybrids targeting type-2 cannabinoid receptors and cholinesterase activity show neuroprotective effects in vitro and amelioration of cognitive impairment in vivo. ACS Chem Neurosci 15(5):955\u2013971","journal-title":"ACS Chem Neurosci"},{"key":"11618_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12010-025-05513-9","volume":"198","author":"MA Babaker","year":"2026","unstructured":"Babaker MA, Alazabi NI, Yousef EM, Haredy SA, Algohary AM, Mansour DF, Ahmed-Farid OA (2026) Taurine mitigates spironolactone-induced hyperkalemia and cognitive dysfunction: a biochemical and histological study in a rat model. Appl Biochem Biotechnol 198:1\u201332","journal-title":"Appl Biochem Biotechnol"},{"issue":"3","key":"11618_CR72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4140\/TCP.n.2026.98","volume":"41","author":"MA Qudoos","year":"2026","unstructured":"Qudoos MA, Elliott DP (2026) Review of donanemab and lecanemab in mild dementia stage of Alzheimer\u2019s disease: progress and challenges. Sr Care Pharmacist 41(3):98\u2013108","journal-title":"Sr Care Pharmacist"},{"issue":"5","key":"11618_CR73","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/s41380-024-02779-z","volume":"30","author":"F Mandino","year":"2025","unstructured":"Mandino F, Shen X, Desrosiers-Gr\u00e9goire G, O\u2019Connor D, Mukherjee B, Owens A et al (2025) Aging-dependent loss of functional connectivity in a mouse model of Alzheimer\u2019s disease and reversal by mGluR5 modulator. Mol Psychiatry 30(5):1730\u20131745","journal-title":"Mol Psychiatry"},{"issue":"9","key":"11618_CR74","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","volume":"7","author":"L Lannfelt","year":"2008","unstructured":"Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J et al (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer\u2019s disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 7(9):779\u2013786","journal-title":"Lancet Neurol"},{"key":"11618_CR75","doi-asserted-by":"publisher","first-page":"104823","DOI":"10.1016\/j.nbd.2020.104823","volume":"139","author":"I Petrushina","year":"2020","unstructured":"Petrushina I, Hovakimyan A, Harahap-Carrillo IS, Davtyan H, Antonyan T, Chailyan G et al (2020) Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials. Neurobiol Dis 139:104823","journal-title":"Neurobiol Dis"},{"issue":"7","key":"11618_CR76","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40265-024-02067-8","volume":"84","author":"JA Hey","year":"2024","unstructured":"Hey JA, Abushakra S, Blennow K, Reiman EM, Hort J, Prins ND et al (2024) Effects of oral ALZ-801\/Valiltramiprosate on plasma biomarkers, brain hippocampal volume, and cognition: results of 2-year single-arm, open-label, phase 2 trial in APOE4 carriers with early Alzheimer\u2019s disease. Drugs 84(7):811\u2013823","journal-title":"Drugs"},{"key":"11618_CR77","doi-asserted-by":"publisher","first-page":"104665","DOI":"10.1016\/j.ebiom.2023.104665","volume":"94","author":"HJ Yu","year":"2023","unstructured":"Yu HJ, Dickson SP, Wang P-N, Chiu M-J, Huang C-C, Chang C-C et al (2023) Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 2a study. EBioMedicine 94:104665","journal-title":"EBioMedicine"},{"issue":"6","key":"11618_CR78","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.14283\/jpad.2024.163","volume":"11","author":"WR Galpern","year":"2024","unstructured":"Galpern WR, Triana-Baltzer G, Li L, Van Kolen K, Timmers M, Haeverans K et al (2024) Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer\u2019s Disease. J Prev Alzheimer\u2019s Disease 11(6):1592\u20131603","journal-title":"J Prev Alzheimer\u2019s Disease"},{"issue":"1","key":"11618_CR79","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","volume":"68","author":"J Gody\u0144","year":"2016","unstructured":"Gody\u0144 J, Jo\u0144czyk J, Panek D, Malawska B (2016) Therapeutic strategies for Alzheimer\u2019s disease in clinical trials. Pharmacol Rep 68(1):127\u2013138","journal-title":"Pharmacol Rep"},{"key":"11618_CR80","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/B978-0-323-98817-9.00029-6","volume":"196","author":"F Panza","year":"2023","unstructured":"Panza F, Solfrizzi V, Daniele A, Lozupone M (2023) Passive tau-based immunotherapy for tauopathies. Handb Clin Neurol 196:611\u2013619","journal-title":"Handb Clin Neurol"},{"key":"11618_CR81","unstructured":"Stockport UK (2025) TargetTau-1: a phase II trial evaluating the efficacy, safety, and tolerability of a monoclonal antibody targeting the tau protein microtubule binding region in patients with early Alzheimer\u2019s disease. Neurology"},{"issue":"15","key":"11618_CR82","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1212\/WNL.0000000000008239","volume":"93","author":"LS Schneider","year":"2019","unstructured":"Schneider LS, Geffen Y, Rabinowitz J, Thomas RG, Schmidt R, Ropele S et al (2019) Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial. Neurology 93(15):e1474\u2013e84","journal-title":"Neurology"},{"key":"11618_CR83","unstructured":"Jordan K, Mahdavi K, Haroon J, Rindner E, Zielinski M, Venkatraman V et al (2022) Neuroimaging data from a phase 2, open-label study of NE3107 in patients with cognitive decline due to degenerative dementias"},{"issue":"5","key":"11618_CR84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/alzrt146","volume":"4","author":"JM Ringman","year":"2012","unstructured":"Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M et al (2012) Oral curcumin for Alzheimer\u2019s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 4(5):43","journal-title":"Alzheimers Res Ther"},{"issue":"21","key":"11618_CR85","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","volume":"289","author":"PS Aisen","year":"2003","unstructured":"Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL et al (2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289(21):2819\u20132826","journal-title":"JAMA"},{"issue":"1","key":"11618_CR86","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13195-021-00882-9","volume":"13","author":"EGB Vijverberg","year":"2021","unstructured":"Vijverberg EGB, Axelsen TM, Bihlet AR, Henriksen K, Weber F, Fuchs K et al (2021) Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD\u2014VIVIAD. Alzheimers Res Ther 13(1):142","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"11618_CR87","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13195-015-0119-0","volume":"7","author":"HB Nygaard","year":"2015","unstructured":"Nygaard HB, Wagner AF, Bowen GS, Good SP, MacAvoy MG, Strittmatter KA et al (2015) A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer\u2019s disease. Alzheimers Res Ther 7(1):35","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"11618_CR88","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/ph15030272","volume":"15","author":"RS Cheke","year":"2022","unstructured":"Cheke RS, Patil VM, Firke SD, Ambhore JP, Ansari IA, Patel HM, Shinde SD, Pasupuleti VR, Hassan MI, Adnan M, Kadri A (2022) Therapeutic outcomes of isatin and its derivatives against multiple diseases: recent developments in drug discovery. Pharmaceuticals 15(3):272","journal-title":"Pharmaceuticals"},{"key":"11618_CR89","doi-asserted-by":"publisher","first-page":"103006","DOI":"10.1016\/j.bioorg.2019.103006","volume":"89","author":"E Riazimontazer","year":"2019","unstructured":"Riazimontazer E, Sadeghpour H, Nadri H, Sakhteman A, K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 TT, Miri R, Edraki N (2019) Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Bioorg Chem 89:103006","journal-title":"Bioorg Chem"},{"issue":"39","key":"11618_CR90","doi-asserted-by":"publisher","first-page":"32309","DOI":"10.1039\/D5RA04722F","volume":"15","author":"IA Seliem","year":"2025","unstructured":"Seliem IA (2025) Design, eco-friendly synthesis, and molecular docking studies of isatin hybrids as promising therapeutic agents (anticancer, anticholinesterase inhibitor, \u03b1-glucosidase inhibitor, and anti-MRSA). RSC Adv 15(39):32309\u201332327","journal-title":"RSC Adv"},{"key":"11618_CR91","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.2174\/0115680266358563250331175140","volume":"25","author":"R Mondal","year":"2025","unstructured":"Mondal R, Paliwal D, Thakur A, Kaushik N (2025) An insight into the recent advancement in anti-Alzheimer\u2019s potential of indole derivatives and their SAR study. Curr Top Med Chem 25:2848\u20132863","journal-title":"Curr Top Med Chem"},{"key":"11618_CR92","doi-asserted-by":"publisher","first-page":"131085","DOI":"10.1016\/j.molstruc.2021.131085","volume":"1245","author":"K Bhagat","year":"2021","unstructured":"Bhagat K, Singh JV, Sharma A, Kaur A, Kumar N, Gulati HK, Singh A, Singh H, Bedi PM (2021) Novel series of triazole containing coumarin and isatin based hybrid molecules as acetylcholinesterase inhibitors. J Mol Struct 1245:131085","journal-title":"J Mol Struct"},{"issue":"14","key":"11618_CR93","doi-asserted-by":"publisher","first-page":"9281","DOI":"10.1039\/D3RA00297G","volume":"13","author":"AS Hassan","year":"2023","unstructured":"Hassan AS, Morsy NM, Aboulthana WM, Ragab A (2023) Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with molecular modeling simulations. RSC Adv 13(14):9281\u20139303","journal-title":"RSC Adv"},{"issue":"16","key":"11618_CR94","first-page":"318","volume":"6","author":"K Vandana","year":"2017","unstructured":"Vandana K, Akash M, Thushara BS, Rajitha K (2017) A review on isatin derivatives with diverse biological activities. World J Pharm Res 6(16):318\u2013332","journal-title":"World J Pharm Res"},{"key":"11618_CR95","unstructured":"Singh GS, Desta ZY (2013) Applications of isatin chemistry in organic synthesis and medicinal chemistry. In: Chemistry and pharmacology of naturally occurring bioactive compounds. pp 73\u2013115"},{"issue":"5","key":"11618_CR96","first-page":"822","volume":"136","author":"M Premanathan","year":"2012","unstructured":"Premanathan M, Radhakrishnan S, Kulangiappar K, Singaravelu G, Thirumalaiarasu V, Sivakumar T, Kathiresan K (2012) Antioxidant & anticancer activities of isatin (1H-indole-2, 3-dione), isolated from the flowers of Couroupita guianensis Aubl. Indian J Med Res 136(5):822\u2013826","journal-title":"Indian J Med Res"},{"issue":"04","key":"11618_CR97","first-page":"1","volume":"12","author":"PV Gandhi","year":"2021","unstructured":"Gandhi PV, Burande SR, Charde MS, Chakole RD (2021) A review on isatin and its derivatives: synthesis, reactions and applications. J Adv Sci Res 12(04):1\u20131","journal-title":"J Adv Sci Res"},{"issue":"5","key":"11618_CR98","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/asia.201301546","volume":"9","author":"A Kumar","year":"2014","unstructured":"Kumar A, Kaur J, Chauhan P, Singh Chimni S (2014) Organocatalytic asymmetric friedel\u2013crafts reaction of sesamol with isatins: access to biologically relevant 3-aryl\u20103\u2010hydroxy\u20102\u2010oxindoles. Chem Asian J 9(5):1305\u20131310","journal-title":"Chem Asian J"},{"issue":"4","key":"11618_CR99","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1021\/acscatal.6b00294","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang G, Liu X, Chen Y, Yang J, Li J, Lin L et al (2016) Diastereoselective and enantioselective alleno-aldol reaction of allenoates with isatins to synthesis of carbinol allenoates catalyzed by gold. ACS Catal 6(4):2482\u20132486","journal-title":"ACS Catal"},{"issue":"26","key":"11618_CR100","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1002\/ejoc.201700399","volume":"2017","author":"UV Subba Reddy","year":"2017","unstructured":"Subba Reddy UV, Chennapuram M, Seki K, Seki C, Anusha B, Kwon E et al (2017) A diamino alcohol catalyzed enantioselective crossed aldol reaction of acetaldehyde with isatins\u2013A concise total synthesis of antitumor agents. Eur J Org Chem 2017(26):3874\u20133885","journal-title":"Eur J Org Chem"},{"key":"11618_CR101","doi-asserted-by":"publisher","first-page":"128900","DOI":"10.1016\/j.molstruc.2020.128900","volume":"1222","author":"R Nath","year":"2020","unstructured":"Nath R, Pathania S, Grover G, Akhtar MJ (2020) Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship. J Mol Struct 1222:128900","journal-title":"J Mol Struct"},{"issue":"3","key":"11618_CR102","first-page":"193","volume":"1","author":"MGA Al-Khuzaie","year":"2022","unstructured":"Al-Khuzaie MGA, Fahad MM, Al-Safi AJ (2022) Synthesis, reaction and biological importance of isatin derivatives. Biomed Chem Sci 1(3):193\u2013206","journal-title":"Biomed Chem Sci"},{"issue":"2","key":"11618_CR103","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1871524917666171113124112","volume":"18","author":"RS Cheke","year":"2018","unstructured":"Cheke RS, Firke SD, Patil RR, Bari SB, Isatin (2018) New hope against convulsion. Cent Nerv Syst Agents Med ChemChem-Central Nerv Syst Agents 18(2):76\u2013101","journal-title":"Cent Nerv Syst Agents Med ChemChem-Central Nerv Syst Agents"},{"issue":"3","key":"11618_CR104","first-page":"193","volume":"1","author":"MG Al-Khuzaie","year":"2022","unstructured":"Al-Khuzaie MG, Fahad MM, Al-Safi AJ (2022) Synthesis, reaction and biological importance of isatin derivatives. Biomed Chem Sci 1(3):193\u2013206","journal-title":"Biomed Chem Sci"},{"issue":"3","key":"11618_CR105","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1023\/A:1017575504084","volume":"37","author":"MA Mironov","year":"2001","unstructured":"Mironov MA, Kleban MI, Mokrushin VS (2001) Novel method for synthesis of isatins. Chem Heterocycl Compd 37(3):368\u2013369","journal-title":"Chem Heterocycl Compd"},{"issue":"34","key":"11618_CR106","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1016\/j.tetlet.2014.06.062","volume":"55","author":"MR Reddy","year":"2014","unstructured":"Reddy MR, Rao NN, Ramakrishna K, Meshram HM (2014) I2\u2013DMSO promoted intramolecular oxidative cyclization of 2-(aryl or alkyl amino)-acetophenones for the synthesis of isatins. Tetrahedron Lett 55(34):4758\u20134762","journal-title":"Tetrahedron Lett"},{"issue":"2","key":"11618_CR107","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3329\/jsr.v2i2.3731","volume":"2","author":"MM Hossain","year":"2010","unstructured":"Hossain MM, Foysal MA, Mahabub M (2010) Microwave-assisted efficient synthesis of isatins and spiro-thiadiazolines under green chemistry protocol. J Sci Res 2(2):322\u2013329","journal-title":"J Sci Res"},{"issue":"3","key":"11618_CR108","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1039\/C8MD00585K","volume":"10","author":"R Kakkar","year":"2019","unstructured":"Kakkar R (2019) Isatin and its derivatives: a survey of recent syntheses, reactions, and applications. MedChemComm 10(3):351\u2013368","journal-title":"MedChemComm"},{"key":"11618_CR109","doi-asserted-by":"publisher","first-page":"627272","DOI":"10.3389\/fmolb.2020.627272","volume":"7","author":"RE Ferraz de Paiva","year":"2021","unstructured":"Ferraz de Paiva RE, Vieira EG, Rodrigues da Silva D, Wegermann CA, Costa Ferreira AM (2021) Anticancer compounds based on isatin-derivatives: Strategies to ameliorate selectivity and efficiency. Front Mol Biosci 7:627272","journal-title":"Front Mol Biosci"},{"issue":"5","key":"11618_CR110","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/ph15050536","volume":"15","author":"S Chowdhary","year":"2022","unstructured":"Chowdhary S, Shalini, Arora A, Kumar V (2022) A mini review on isatin, an anticancer scaffold with potential activities against neglected tropical diseases (NTDs). Pharmaceuticals 15(5):536","journal-title":"Pharmaceuticals"},{"issue":"4","key":"11618_CR111","first-page":"501","volume":"16","author":"F Caraci","year":"2017","unstructured":"Caraci F, Sultana J, Drago F, Spina E (2017) Clinically relevant drug interactions with anti-Alzheimer\u2019s drugs. CNS Neurol Disord-Drug Targets-CNS Neurol Disord. 16(4):501\u2013513","journal-title":"CNS Neurol Disord-Drug Targets-CNS Neurol Disord"},{"issue":"2","key":"11618_CR112","first-page":"13","volume":"71","author":"A Dimkovski","year":"2024","unstructured":"Dimkovski A, Mihajloska E, Panovska AP (2024) Recent advances in isatin-derived hybrids: promising multifunctional agents for drug development. Macedonian Pharm Bull\/Makedonsko Farmacevtski Bilten 71(2):13\u201325","journal-title":"Macedonian Pharm Bull\/Makedonsko Farmacevtski Bilten"},{"issue":"1","key":"11618_CR113","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s44371-025-00395-6","volume":"2","author":"H Sharmah","year":"2025","unstructured":"Sharmah H, Ahmed LA, Deka B, Bharali D, Gogoi B, Patowary P (2025) Exploring the potential of coumarin-indole hybrid scaffold as promising pharmacological agents: a review. Discov Chem 2(1):320","journal-title":"Discov Chem"},{"key":"11618_CR114","doi-asserted-by":"publisher","first-page":"106750","DOI":"10.1016\/j.bioorg.2023.106750","volume":"139","author":"P Sharma","year":"2023","unstructured":"Sharma P, Gupta GD, Asati V (2023) Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as \u03b1-glucosidase inhibitors. Bioorg Chem 139:106750","journal-title":"Bioorg Chem"},{"issue":"3","key":"11618_CR115","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5530\/ijper.51.3.72","volume":"51","author":"V Asati","year":"2017","unstructured":"Asati V, Bharti SK, Rathore A, Mahapatra DK (2017) SWFB and GA strategies for variable selection in QSAR studies for the validation of thiazolidine-2, 4-dione derivatives as promising antitumor candidates. Indian J Pharm Educ Res 51(3):436\u2013451","journal-title":"Indian J Pharm Educ Res"},{"key":"11618_CR116","doi-asserted-by":"publisher","first-page":"100124","DOI":"10.1016\/j.crstbi.2024.100124","volume":"7","author":"B Saha","year":"2024","unstructured":"Saha B, Das A, Jangid K, Kumar A, Kumar V, Jaitak V (2024) Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer\u2019s disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM\/GBSA, ADME and MD Simulation study. Curr Res Struct Biology 7:100124","journal-title":"Curr Res Struct Biology"},{"issue":"1","key":"11618_CR117","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00044-015-1442-5","volume":"25","author":"V Asati","year":"2016","unstructured":"Asati V, Bajaj S, Mahapatra DK, Bharti SK (2016) Molecular modeling studies of some thiazolidine-2, 4-dione derivatives as 15-PGDH inhibitors. Med Chem Res 25(1):94\u2013108","journal-title":"Med Chem Res"},{"key":"11618_CR118","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.molstruc.2016.12.006","volume":"1133","author":"V Asati","year":"2017","unstructured":"Asati V, Bharti SK, Budhwani AK (2017) 3D-QSAR and virtual screening studies of thiazolidine-2, 4-dione analogs: Validation of experimental inhibitory potencies towards PIM-1 kinase. J Mol Struct 1133:278\u2013293","journal-title":"J Mol Struct"},{"issue":"1","key":"11618_CR119","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/slct.201702392","volume":"3","author":"V Asati","year":"2018","unstructured":"Asati V, Thakur SS, Upmanyu N, Bharti SK (2018) Virtual screening, molecular docking, and DFT studies of some thiazolidine-2, 4\u2010diones as potential PIM\u20101 kinase inhibitors. ChemistrySelect 3(1):127\u2013135","journal-title":"ChemistrySelect"},{"key":"11618_CR120","doi-asserted-by":"publisher","first-page":"135596","DOI":"10.1016\/j.molstruc.2023.135596","volume":"1287","author":"S Gupta","year":"2023","unstructured":"Gupta S, Baweja GS, Gupta GD, Asati V (2023) Identification of potential N-substituted 5-benzylidenethiazolidine-2, 4-dione derivatives as \u03b1-amylase inhibitors: computational cum synthetic studies. J Mol Struct 1287:135596","journal-title":"J Mol Struct"},{"key":"11618_CR121","doi-asserted-by":"publisher","first-page":"128375","DOI":"10.1016\/j.molstruc.2020.128375","volume":"1217","author":"V Asati","year":"2020","unstructured":"Asati V, Agarwal S, Mishra M, Das R, Kashaw SK (2020) Structural prediction of novel pyrazolo-pyrimidine derivatives against PIM-1 kinase: In-silico drug design studies. J Mol Struct 1217:128375","journal-title":"J Mol Struct"},{"issue":"20","key":"11618_CR122","doi-asserted-by":"publisher","first-page":"10422","DOI":"10.1080\/07391102.2021.1944320","volume":"40","author":"V Asati","year":"2022","unstructured":"Asati V, Bharti SK, Das R, Kashaw V, Kashaw SK (2022) Discovery of novel ALK2 inhibitors of pyrazolo-pyrimidines: a computational study. J Biomol Struct Dyn 40(20):10422\u201310436","journal-title":"J Biomol Struct Dyn"},{"key":"11618_CR123","doi-asserted-by":"publisher","first-page":"131079","DOI":"10.1016\/j.molstruc.2021.131079","volume":"1245","author":"A Anant","year":"2021","unstructured":"Anant A, Ali A, Ali A, Gupta GD, Asati V (2021) A Computational approach to discover potential quinazoline derivatives against CDK4\/6 kinase. J Mol Struct 1245:131079","journal-title":"J Mol Struct"},{"issue":"1","key":"11618_CR124","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40203-022-00121-5","volume":"10","author":"A Rathore","year":"2022","unstructured":"Rathore A, Asati V, Mishra M, Das R, Kashaw V, Kashaw SK (2022) Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia. Silico Pharmacol 10(1):7","journal-title":"Silico Pharmacol"},{"issue":"4","key":"11618_CR125","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/1573409914666181003153249","volume":"15","author":"V Asati","year":"2019","unstructured":"Asati V, Ghode P, Bajaj S, Jain SK, Bharti SK (2019) 3D-QSAR and molecular docking studies on oxadiazole substituted benzimidazole derivatives: validation of experimental inhibitory potencies towards COX-2. Curr Comput-Aided Drug Des 15(4):277\u2013293","journal-title":"Curr Comput-Aided Drug Des"},{"issue":"1","key":"11618_CR126","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1574362416666210906155929","volume":"17","author":"C Mallick","year":"2022","unstructured":"Mallick C, Mishra M, Asati V, Kashaw V, Das R, Iyer AK, Kashaw SK (2022) Integrated computational analysis on some indolo-quinoline derivatives for the development of novel antiplasmodium agents: CoMFA, pharmacophore mapping, molecular docking and ADMET studies. Curr Signal Transduct Ther 17(1):12\u201358","journal-title":"Curr Signal Transduct Ther"},{"issue":"1","key":"11618_CR127","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/1574362418666221130164014","volume":"18","author":"C Mallick","year":"2023","unstructured":"Mallick C, Mishra M, Asati V, Kashaw V, Das R, Kashaw SK (2023) In silico-based structural prediction, molecular docking and ADMET analysis of novel imidazo-quinoline derivatives as pf purine nucleoside phosphorylase inhibitors. Curr Signal Transduct Ther 18(1):24\u201353","journal-title":"Curr Signal Transduct Ther"},{"key":"11618_CR128","doi-asserted-by":"publisher","first-page":"137098","DOI":"10.1016\/j.molstruc.2023.137098","volume":"1299","author":"P Patel","year":"2024","unstructured":"Patel P, Shakya R, Asati V, Kurmi BD, Verma SK, Gupta GD, Rajak H (2024) Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: SAR and docking studies (2010 to till date). J Mol Struct 1299:137098","journal-title":"J Mol Struct"},{"issue":"19","key":"11618_CR129","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2174\/0115680266299847240328045737","volume":"24","author":"D Shukla","year":"2024","unstructured":"Shukla D, Suryavanshi A, Bharti SK, Asati V, Mahapatra DK (2024) Recent advances in the treatment and management of alzheimer\u2019s disease: a precision medicine perspective. Curr Top Med Chem 24(19):1699\u20131737","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"11618_CR130","doi-asserted-by":"publisher","first-page":"e70248","DOI":"10.1002\/ardp.70248","volume":"359","author":"AD Bagul","year":"2026","unstructured":"Bagul AD, Irfan M, Jaitak A, Asati V, Goyal K, Monga V (2026) Current landscape of indole hybrids in the design and development of anti-Alzheimer agents: structural insights, therapeutic potential and in silico studies. Arch Pharm 359(5):e70248","journal-title":"Arch Pharm"},{"key":"11618_CR131","doi-asserted-by":"publisher","DOI":"10.2174\/0115734099359621250320073543","author":"N Maliyakkal","year":"2025","unstructured":"Maliyakkal N, Taslimi P, T\u00fcz\u00fcn B, Menadi S, Cacan E, Beeran AA et al (2025) Cholinesterase inhibition and anticancer properties of [4-(benzyloxy) phenyl]{methylidene} hydrazinylidene]-1, 3-dihydro-2H-indol-2-ones using Swiss target-guided prediction. Curr Comput-Aided Drug Des. https:\/\/doi.org\/10.2174\/0115734099359621250320073543","journal-title":"Curr Comput-Aided Drug Des"},{"key":"11618_CR132","doi-asserted-by":"publisher","first-page":"140717","DOI":"10.1016\/j.molstruc.2024.140717","volume":"1324","author":"Y Tamaddon-Abibigloo","year":"2025","unstructured":"Tamaddon-Abibigloo Y, Dastmalchi S, Razzaghi-Asl N, K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 TT, Mojarrad JS (2025) Evaluation of isatin-1, 3, 5-triazine-benzylamine hybrids as multi-target directed ligands against Alzheimer\u2019s disease. J Mol Struct 1324:140717","journal-title":"J Mol Struct"},{"key":"11618_CR133","doi-asserted-by":"publisher","first-page":"140503","DOI":"10.1016\/j.molstruc.2024.140503","volume":"1322","author":"RR Thomas","year":"2025","unstructured":"Thomas RR, Trisciuzzi D, Sudevan ST, Gambacorta N, Catto M, Kumar S et al (2025) Isatin derived morpholine and piperazine derivatives as acetylcholinesterase inhibitors. J Mol Struct 1322:140503","journal-title":"J Mol Struct"},{"issue":"10","key":"11618_CR134","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3390\/molecules30102121","volume":"30","author":"A Dimkovski","year":"2025","unstructured":"Dimkovski A, Dobri\u010di\u0107 V, Simi\u0107 MR, Jurhar Pavlova M, Mihajloska E, Sterjev Z et al (2025) Synthesis, biological evaluation, and molecular docking studies of novel Coumarin\u2013Triazole\u2013Isatin hybrids as selective butyrylcholinesterase inhibitors. Molecules 30(10):2121","journal-title":"Molecules"},{"key":"11618_CR135","doi-asserted-by":"publisher","first-page":"140126","DOI":"10.1016\/j.molstruc.2024.140126","volume":"1321","author":"M Elhag","year":"2025","unstructured":"Elhag M, Abdelwahab HE, El Sadek MM, Hamed EA, Dambruoso P, Casapullo A et al (2025) Microwave-assisted synthesis of indoloquinoxaline derivatives as promising anti-alzheimer agents: DFT and molecular docking study. J Mol Struct 1321:140126","journal-title":"J Mol Struct"},{"key":"11618_CR136","doi-asserted-by":"publisher","first-page":"107355","DOI":"10.1016\/j.bioorg.2024.107355","volume":"147","author":"Y Tamaddon-Abibigloo","year":"2024","unstructured":"Tamaddon-Abibigloo Y, Dastmalchi S, Razzaghi-Asl N, Mojarrad JS (2024) Design, synthesis, in vitro and in silico evaluations of new isatin-triazine-aniline hybrids as potent anti-Alzheimer multi-target directed lead compounds. Bioorg Chem 147:107355","journal-title":"Bioorg Chem"},{"key":"11618_CR137","doi-asserted-by":"publisher","first-page":"135351","DOI":"10.1016\/j.molstruc.2023.135351","volume":"1284","author":"S Khan","year":"2023","unstructured":"Khan S, Ullah H, Hussain R, Khan Y, Khan MU, Khan M et al (2023) Synthesis, in vitro bio-evaluation, and molecular docking study of thiosemicarbazone-based isatin\/bis-Schiff base hybrid analogues as effective cholinesterase inhibitors. J Mol Struct 1284:135351","journal-title":"J Mol Struct"},{"issue":"1","key":"11618_CR138","doi-asserted-by":"publisher","first-page":"2286935","DOI":"10.1080\/14756366.2023.2286935","volume":"39","author":"KN Alcorn","year":"2024","unstructured":"Alcorn KN, Oberhauser IA, Politeski MD, Eckroat TJ (2024) Evaluation of N-alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors. J Enzyme Inhib Med Chem 39(1):2286935","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11618_CR139","doi-asserted-by":"publisher","first-page":"129037","DOI":"10.1016\/j.bmcl.2022.129037","volume":"77","author":"KM Reiland","year":"2022","unstructured":"Reiland KM, Eckroat TJ (2022) Selective butyrylcholinesterase inhibition by isatin dimers and 3-indolyl-3-hydroxy-2-oxindole dimers. Bioorg Med Chem Lett 77:129037","journal-title":"Bioorg Med Chem Lett"},{"issue":"19","key":"11618_CR140","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1055\/s-0041-1737343","volume":"54","author":"CS Marques","year":"2022","unstructured":"Marques CS, L\u00f3pez \u00d3, Leitzbach L, Fern\u00e1ndez-Bola\u00f1os JG, Stark H, Burke AJ (2022) Survey of new, small-molecule isatin-based oxindole hybrids as multi-targeted drugs for the treatment of Alzheimer\u2019s disease. Synthesis 54(19):4304\u20134319","journal-title":"Synthesis"},{"key":"11618_CR141","doi-asserted-by":"publisher","first-page":"131085","DOI":"10.1016\/j.molstruc.2021.131085","volume":"1245","author":"K Bhagat","year":"2021","unstructured":"Bhagat K, Singh JV, Sharma A, Kaur A, Kumar N, Gulati HK et al (2021) Novel series of triazole containing coumarin and isatin based hybrid molecules as acetylcholinesterase inhibitors. J Mol Struct 1245:131085","journal-title":"J Mol Struct"},{"issue":"1","key":"11618_CR142","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1080\/14756366.2021.1916009","volume":"36","author":"DAS Kitagawa","year":"2021","unstructured":"Kitagawa DAS, Rodrigues RB, Silva TN, Dos Santos WV, da Rocha VCV, de Almeida JSFD et al (2021) Design, synthesis, in silico studies and in vitro evaluation of isatin-pyridine oximes hybrids as novel acetylcholinesterase reactivators. J Enzyme Inhib Med Chem 36(1):1369\u20131376","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"12","key":"11618_CR143","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00044-021-02800-y","volume":"30","author":"SM Davis","year":"2021","unstructured":"Davis SM, Eckroat TJ (2021) Isatin-linked 4, 4-dimethyl-5-methylene-4, 5-dihydrothiazole-2-thiols for inhibition of acetylcholinesterase. Med Chem Res 30(12):2289\u20132300","journal-title":"Med Chem Res"},{"issue":"1","key":"11618_CR144","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1386207323666201211092138","volume":"25","author":"B Macha","year":"2022","unstructured":"Macha B, Kulkarni R, Garige AK, Palabindala R, Akkinepally R, Garlapati A, Design (2022) Synthesis and biological evaluation of new cycloalkyl fused quinolines tethered to isatin schiff bases as cholinesterase inhibitors. Comb Chem High Throughput Screen 25(1):167\u2013186","journal-title":"Comb Chem High Throughput Screen"},{"key":"11618_CR145","doi-asserted-by":"publisher","first-page":"103006","DOI":"10.1016\/j.bioorg.2019.103006","volume":"89","author":"E Riazimontazer","year":"2019","unstructured":"Riazimontazer E, Sadeghpour H, Nadri H, Sakhteman A, K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 TT, Miri R et al (2019) Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Bioorg Chem 89:103006","journal-title":"Bioorg Chem"},{"key":"11618_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11030-025-11129-2","volume":"29","author":"Y-Y Zhong","year":"2025","unstructured":"Zhong Y-Y, Deng JZ, Wang Q, Chen L, Yang Z-H, Zhang Y-M et al (2025) Development of novel melatonin-isatin hybrids as multifunctional agents for Alzheimer\u2019s disease. Mol Divers 29:1\u201316","journal-title":"Mol Divers"},{"issue":"5","key":"11618_CR147","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/1573409919666230523114134","volume":"20","author":"T Muthukumaran","year":"2024","unstructured":"Muthukumaran T, K AK M, Saleshier F (2024) Docking, synthesis, and in vitro anti-depressant activity of certain isatin derivatives. Curr Comput-Aided Drug Des 20(5):431\u2013440","journal-title":"Curr Comput-Aided Drug Des"},{"issue":"1","key":"11618_CR148","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13765-024-00917-3","volume":"67","author":"N Maliyakkal","year":"2024","unstructured":"Maliyakkal N, Oh JM, Kumar S, Gahori P, Tengli A, Beeran AA et al (2024) Synthesis, biochemistry, and in silico investigations of isatin-based hydrazone derivatives as monoamine oxidase inhibitors. Appl Biol Chem 67(1):63","journal-title":"Appl Biol Chem"},{"issue":"1","key":"11618_CR149","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41598-024-51728-x","volume":"14","author":"S Kumar","year":"2024","unstructured":"Kumar S, Oh JM, Prabhakaran P, Awasti A, Kim H, Mathew B (2024) Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect. Sci Rep 14(1):1264","journal-title":"Sci Rep"},{"issue":"5","key":"11618_CR150","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1080\/07391102.2023.2214216","volume":"42","author":"S Kumar","year":"2024","unstructured":"Kumar S, Jayan J, Manoharan A, Benny F, Abdelgawad MA, Ghoneim MM et al (2024) Discerning of isatin-based monoamine oxidase (MAO) inhibitors for neurodegenerative disorders by exploiting 2D, 3D-QSAR modelling and molecular dynamics simulation. J Biomol Struct Dyn 42(5):2328\u20132340","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"11618_CR151","first-page":"438","volume":"26","author":"A Mesripour","year":"2023","unstructured":"Mesripour A, Jafari E, Hajibeiki MR, Hassanzadeh F (2023) Design, synthesis, docking, and antidepressant activity evaluation of isatin derivatives bearing Schiff bases. Iran J Basic Med Sci 26(4):438","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"11618_CR152","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10822-025-00588-2","volume":"39","author":"N Negi","year":"2025","unstructured":"Negi N, Ayyannan SR, Tripathi RKP (2025) Multi-targeted benzylpiperidine\u2013isatin hybrids: design, synthesis, biological and in silico evaluation as monoamine oxidases and acetylcholinesterase inhibitors for neurodegenerative disease therapies. J Comput Aided Mol Des 39(1):10","journal-title":"J Comput Aided Mol Des"},{"issue":"9","key":"11618_CR153","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1080\/07391102.2023.2224887","volume":"42","author":"S Kumar","year":"2024","unstructured":"Kumar S, Jaiswal S, Gupta SK, Ayyannan SR (2024) Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation. J Biomol Struct Dyn 42(9):4710\u20134729","journal-title":"J Biomol Struct Dyn"},{"issue":"14","key":"11618_CR154","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/cmdc.201900277","volume":"14","author":"MS Vishnu","year":"2019","unstructured":"Vishnu MS, Pavankumar V, Kumar S, Raja AS (2019) Experimental and computational evaluation of piperonylic acid derived hydrazones bearing isatin moieties as dual inhibitors of cholinesterases and monoamine oxidases. ChemMedChem 14(14):1359\u20131376","journal-title":"ChemMedChem"},{"issue":"7","key":"11618_CR155","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/molecules30071421","volume":"30","author":"R Wang","year":"2025","unstructured":"Wang R, Zhang Z, Jiang W, Liu J, Tian C, Wang M (2025) Novel isatin\u2013chalcone hybrid molecules: design, synthesis and anti-neuroinflammatory activity evaluation. Molecules 30(7):1421","journal-title":"Molecules"},{"issue":"6","key":"11618_CR156","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/brainsci12060806","volume":"12","author":"B Mavroidi","year":"2022","unstructured":"Mavroidi B, Kaminari A, Matiadis D, Hadjipavlou-Litina D, Pelecanou M, Tzinia A et al (2022) The prophylactic and multimodal activity of two isatin thiosemicarbazones against Alzheimer\u2019s disease in vitro. Brain Sci 12(6):806","journal-title":"Brain Sci"},{"issue":"3","key":"11618_CR157","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2174\/0115701794335274240910111137","volume":"22","author":"MM Al-Mahadeen","year":"2025","unstructured":"Al-Mahadeen MM, Jaber AM, Al-Najjar BO, Khanfar MA, El-Abadelah MM (2025) Novel N-substituted Isatin-oxoindolin-1 H-benzo [D] imidazole fumarate as a new class of JNK3 Inhibitor: design, synthesis, molecular modeling and its biological activity. Curr Org Synth 22(3):410\u2013418","journal-title":"Curr Org Synth"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11618-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:02:18Z","timestamp":1793858538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11618-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":157,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11618"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11618-y","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}